These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 589316)

  • 21. Decreased response of epinephrine and norepinephrine to insulin-induced hypoglycemia in diabetic autonomic neuropathy.
    Horie H; Hanafusa T; Matsuyama T; Namba M; Nonaka K; Tarui S; Yamatodani A; Wada H
    Horm Metab Res; 1984 Aug; 16(8):398-401. PubMed ID: 6381272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes.
    Ranjan A; Schmidt S; Madsbad S; Holst JJ; Nørgaard K
    Diabetes Obes Metab; 2016 Apr; 18(4):410-8. PubMed ID: 26743775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of the autonomic nervous system in the control of glucagon release during insulin hypoglycaemia in the calf.
    Vaughan NJ; Bloom SR; Ogawa O; Bircham PM; Edwards AV
    Experientia; 1973; 29(7):805-6. PubMed ID: 4724704
    [No Abstract]   [Full Text] [Related]  

  • 24. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.
    Ward WK; Bolgiano DC; McKnight B; Halter JB; Porte D
    J Clin Invest; 1984 Oct; 74(4):1318-28. PubMed ID: 6384269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
    Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH
    J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of exogenously administered glucagon versus spontaneous endogenous counter-regulation on glycaemic recovery from insulin-induced hypoglycaemia in patients with type 2 diabetes treated with a novel glucokinase activator, AZD1656, and metformin.
    Krentz AJ; Morrow L; Petersson M; Norjavaara E; Hompesch M
    Diabetes Obes Metab; 2014 Nov; 16(11):1096-101. PubMed ID: 24909093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin resistance and decreased insulin response to glucose in lean type 2 diabetics.
    Wajngot A; Roovete A; Vranić M; Luft R; Efendić S
    Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4432-6. PubMed ID: 6750603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study.
    Ranjan A; Wendt SL; Schmidt S; Madsbad S; Holst JJ; Madsen H; Knudsen CB; Jørgensen JB; Nørgaard K
    Basic Clin Pharmacol Toxicol; 2018 Mar; 122(3):322-330. PubMed ID: 28922582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia.
    Porcellati F; Pampanelli S; Rossetti P; Busciantella Ricci N; Marzotti S; Lucidi P; Santeusanio F; Bolli GB; Fanelli CG
    Diabetologia; 2007 Feb; 50(2):422-30. PubMed ID: 17160672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucagon secretion in rats with non-insulin-dependent diabetes: an in vivo and in vitro study.
    Giroix MH; Portha B; Kergoat M; Picon L
    Diabete Metab; 1984 Jan; 10(1):12-7. PubMed ID: 6724097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Familial idiopathic haemochromatosis with diabetes. Study of glucagon and growth hormone secretions (author's transl)].
    Passa P; Zygelman M; Altman JJ; Fiet J
    Nouv Presse Med; 1978 Feb; 7(5):343-7. PubMed ID: 634772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous intraperitoneal insulin infusion partly restores the glucagon response to hypoglycaemia in type 1 diabetic patients.
    Oskarsson PR; Lins PE; Backman L; Adamson UC
    Diabetes Metab; 2000 Apr; 26(2):118-24. PubMed ID: 10804326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The significance of impaired pancreatic polypeptide and epinephrine responses to hypoglycemia in patients with insulin-dependent diabetes mellitus.
    Kennedy FP; Bolli GB; Go VL; Cryer PE; Gerich JE
    J Clin Endocrinol Metab; 1987 Mar; 64(3):602-8. PubMed ID: 3818892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Counterregulatory hormones in insulin-treated diabetic patients admitted to an accident and emergency department with hypoglycaemia.
    Hvidberg A; Christensen NJ; Hilsted J
    Diabet Med; 1998 Mar; 15(3):199-204. PubMed ID: 9545120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose modulation of amino acid-induced glucagon and insulin release in the isolated perfused rat pancreas.
    Pagliara AS; Stillings SN; Hover B; Martin DM; Matschinsky FM
    J Clin Invest; 1974 Oct; 54(4):819-32. PubMed ID: 4430716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cholinergic regulation of insulin and glucagon secretion in healthy people and in patients with non-insulin dependent diabetes].
    Czyźyk A; Lawecki J; Strycek-Kaminska D
    Z Gesamte Inn Med; 1981 Jan; 36(2):43-7. PubMed ID: 7013296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: no causal relation with diabetic autonomic neuropathy.
    Ryder RE; Owens DR; Hayes TM; Ghatei MA; Bloom SR
    BMJ; 1990 Oct; 301(6755):783-7. PubMed ID: 2224265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.
    Raskin P; Fujita Y; Unger RH
    J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucagon release induced by pancreatic nerve stimulation in the dog.
    Marliss EB; Girardier L; Seydoux J; Wollheim CB; Kanazawa Y; Orci L; Renold AE; Porte D
    J Clin Invest; 1973 May; 52(5):1246-59. PubMed ID: 4349486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.